{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:00:00Z","timestamp":1774785600207,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11904-008-0006-4","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T14:05:14Z","timestamp":1201788314000},"page":"33-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The potential of RNA interference-based therapies for viral infections"],"prefix":"10.1007","volume":"5","author":[{"given":"Diana D.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"6_CR1","unstructured":"Rossi JJ: Interference and inhibition: RNAi mechanisms and therapeutic prospects. Presented at the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Sydney, Australia; July 22\u201325, 2007."},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1196\/annals.1348.006","volume":"1082","author":"M. Li","year":"2006","unstructured":"Li M, Li H, Rossi JJ: RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy. Ann N Y Acad Sci 2006, 1082:172\u2013179.","journal-title":"Ann N Y Acad Sci"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nbt1206","volume":"24","author":"M.A. Robbins","year":"2006","unstructured":"Robbins MA, Li M, Leung I, et al.: Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol 2006, 24:566\u2013571.","journal-title":"Nat Biotechnol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1196\/annals.1281.008","volume":"1002","author":"A. Michienzi","year":"2003","unstructured":"Michienzi A, Castanotto D, Lee N, et al.: RNA-mediated inhibition of HIV in a gene therapy setting. Ann N Y Acad Sci 2003, 1002:63\u201371.","journal-title":"Ann N Y Acad Sci"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/sj.gt.3302977","volume":"14","author":"L. Scherer","year":"2007","unstructured":"Scherer L, Rossi JJ, Weinberg MS: Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther 2007, 14:1057\u20131064.","journal-title":"Gene Ther"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.cr.7290371","volume":"15","author":"M.L. Yeung","year":"2005","unstructured":"Yeung ML, Bennasser Y, Le SY, Jeang KT: siRNA, miRNA and HIV: promises and challenges. Cell Res 2005, 15:935\u2013946.","journal-title":"Cell Res"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-143-2-200507190-00033","volume":"143","author":"J.F. Wilson","year":"2005","unstructured":"Wilson JF: Gene therapy yields to RNA interference. Ann Intern Med 2005, 143:161\u2013164.","journal-title":"Ann Intern Med"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/104303404322886101","volume":"15","author":"R.G. Amado","year":"2004","unstructured":"Amado RG, Mitsuyasu RT, Rosenblatt JD, et al.: Antihuman immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther 2004, 15:251\u2013262.","journal-title":"Hum Gene Ther"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.0608138103","volume":"103","author":"B.L. Levine","year":"2006","unstructured":"Levine BL, Humeau LM, Boyer J, et al.: Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci U S A 2006, 103:17372\u201317377.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.genet.36.043002.091619","volume":"36","author":"M. Tijsterman","year":"2002","unstructured":"Tijsterman M, Ketting RF, Plasterk RH: The genetics of RNA silencing. Annu Rev Genet 2002, 36:489\u2013519.","journal-title":"Annu Rev Genet"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/sj.gt.3302645","volume":"13","author":"J.N. Leonard","year":"2006","unstructured":"Leonard JN, Schaffer DV: Antiviral RNAi therapy: emerging approaches for hitting a moving target. Gene Ther 2006, 13:532\u2013540.","journal-title":"Gene Ther"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/437601b","volume":"437","author":"E. Check","year":"2005","unstructured":"Check E: Pioneering HIV treatment would use interference and gene therapy. Nature 2005, 437:601.","journal-title":"Nature"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.gt.3302727","volume":"13","author":"D. Grimm","year":"2006","unstructured":"Grimm D, Kay MA: Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Ther 2006, 13:563\u2013575.","journal-title":"Gene Ther"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2006.07.007","volume":"126","author":"D.M. Dykxhoorn","year":"2006","unstructured":"Dykxhoorn DM, Lieberman J: Knocking down disease with siRNAs. Cell 2006, 126:231\u2013235.","journal-title":"Cell"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1371\/journal.pmed.0030242","volume":"3","author":"D.M. Dykxhoorn","year":"2006","unstructured":"Dykxhoorn DM, Lieberman J: Silencing viral infection. PLoS Med 2006, 3:e242.","journal-title":"PLoS Med"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrd2310","volume":"6","author":"A. de Fougerolles","year":"2007","unstructured":"de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6:443\u2013453.","journal-title":"Nat Rev Drug Discov"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nm0303-266","volume":"9","author":"P.D. Zamore","year":"2003","unstructured":"Zamore PD, Aronin N: siRNAs knock down hepatitis. Nat Med 2003, 9:266\u2013267.","journal-title":"Nat Med"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1128\/JVI.77.21.11531-11535.2003","volume":"77","author":"D. Boden","year":"2003","unstructured":"Boden D, Pusch O, Lee F, et al.: Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003, 77:11531\u201311535.","journal-title":"J Virol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","volume":"78","author":"A.T. Das","year":"2004","unstructured":"Das AT, Brummelkamp TR, Westerhout EM, et al.: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004, 78:2601\u20132605.","journal-title":"J Virol"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/nar\/gki220","volume":"33","author":"E.M. Westerhout","year":"2005","unstructured":"Westerhout EM, Ooms M, Vink M, et al.: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005, 33:796\u2013804.","journal-title":"Nucleic Acids Res"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1128\/JVI.79.11.7050-7058.2005","volume":"79","author":"J.A. Wilson","year":"2005","unstructured":"Wilson JA, Richardson CD: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J Virol 2005, 79:7050\u20137058.","journal-title":"J Virol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature04263","volume":"439","author":"D. Palliser","year":"2006","unstructured":"Palliser D, Chowdhury D, Wang QY, et al.: An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 2006, 439:89\u201394.","journal-title":"Nature"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm1164","volume":"11","author":"V. Bitko","year":"2005","unstructured":"Bitko V, Musiyenko A, Shulyayeva O, Barik S: Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005, 11:50\u201355.","journal-title":"Nat Med"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q. Ge","year":"2004","unstructured":"Ge Q, Filip L, Bai A, et al.: Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A 2004, 101:8676\u20138681.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1073\/pnas.0402630101","volume":"101","author":"S.M. Tompkins","year":"2004","unstructured":"Tompkins SM, Lo CY, Tumpey TM, Epstein SL: Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A 2004, 101:8682\u20138686.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","volume":"11","author":"B.J. Li","year":"2005","unstructured":"Li BJ, Tang Q, Cheng D, et al.: Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005, 11:944\u2013951.","journal-title":"Nat Med"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1371\/journal.pmed.0030096","volume":"3","author":"P. Kumar","year":"2006","unstructured":"Kumar P, Lee SK, Shankar P, Manjunath N: A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med 2006, 3:e96.","journal-title":"PLoS Med"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.20702","volume":"41","author":"D.V. Morrissey","year":"2005","unstructured":"Morrissey DV, Blanchard K, Shaw L, et al.: Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 2005, 41:1349\u20131356.","journal-title":"Hepatology"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"D.V. Morrissey","year":"2005","unstructured":"Morrissey DV, Lockridge JA, Shaw L, et al.: Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005, 23:1002\u20131007.","journal-title":"Nat Biotechnol"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.gt.3302846","volume":"14","author":"C.C. Chen","year":"2007","unstructured":"Chen CC, Ko TM, Ma HI, et al.: Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. Gene Ther 2007, 14:11\u201319.","journal-title":"Gene Ther"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nbt824","volume":"21","author":"A.P. McCaffrey","year":"2003","unstructured":"McCaffrey AP, Nakai H, Pandey K, et al.: Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003, 21:639\u2013644.","journal-title":"Nat Biotechnol"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.antiviral.2006.05.022","volume":"73","author":"R.S. Ying","year":"2007","unstructured":"Ying RS, Zhu C, Fan XG, et al.: Hepatitis B virus is inhibited by RNA interference in cell culture and in mice. Antiviral Res 2007, 73:24\u201330.","journal-title":"Antiviral Res"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0016-5085(03)00720-0","volume":"125","author":"C. Klein","year":"2003","unstructured":"Klein C, Bock CT, Wedemeyer H, et al.: Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 2003, 125:9\u201318.","journal-title":"Gastroenterology"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/01.CIR.0000160360.02040.AB","volume":"111","author":"S. Merl","year":"2005","unstructured":"Merl S, Michaelis C, Jaschke B, et al.: Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 2005, 111:1583\u20131592.","journal-title":"Circulation"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nm737","volume":"8","author":"D. Xiong","year":"2002","unstructured":"Xiong D, Lee GH, Badorff C, et al.: Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med 2002, 8:872\u2013877.","journal-title":"Nat Med"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/sj.gt.3302948","volume":"14","author":"H. Fechner","year":"2007","unstructured":"Fechner H, Pinkert S, Wang X, et al.: Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther 2007, 14:960\u2013971.","journal-title":"Gene Ther"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.1113329","volume":"309","author":"C.L. Jopling","year":"2005","unstructured":"Jopling CL, Yi M, Lancaster AM, et al.: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577\u20131581.","journal-title":"Science"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm828","volume":"9","author":"E. Song","year":"2003","unstructured":"Song E, Lee SK, Wang J, et al.: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003, 9:347\u2013351.","journal-title":"Nat Med"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1525-1438.2006.00384.x","volume":"16","author":"X.Y. Niu","year":"2006","unstructured":"Niu XY, Peng ZL, Duan WQ, et al.: Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int J Gynecol Cancer 2006, 16:743\u2013751.","journal-title":"Int J Gynecol Cancer"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbrc.2007.06.182","volume":"361","author":"T. Yokota","year":"2007","unstructured":"Yokota T, Iijima S, Kubodera T, et al.: Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C. Biochem Biophys Res Commun 2007, 361:294\u2013300.","journal-title":"Biochem Biophys Res Commun"},{"key":"6_CR41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm725","volume":"8","author":"C.D. Novina","year":"2002","unstructured":"Novina CD, Murray MF, Dykxhoorn DM, et al.: siRNA-directed inhibition of HIV-1 infection. Nat Med 2002, 8:681\u2013686.","journal-title":"Nat Med"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1073\/pnas.232688199","volume":"100","author":"X.F. Qin","year":"2003","unstructured":"Qin XF, An DS, Chen IS, Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 2003, 100:183\u2013188.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-2-1","volume":"2","author":"J. Anderson","year":"2005","unstructured":"Anderson J, Akkina R: HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005, 2:1.","journal-title":"AIDS Res Ther"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2005.03.010","volume":"22","author":"Y. Bennasser","year":"2005","unstructured":"Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005, 22:607\u2013619.","journal-title":"Immunity"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/aid.2006.22.401","volume":"22","author":"E. Cave","year":"2006","unstructured":"Cave E, Weinberg MS, Cilliers T, et al.: Silencing of HIV-1 subtype C primary isolates by expressed small hairpin RNAs targeted to gag. AIDS Res Hum Retroviruses 2006, 22:401\u2013410.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1182\/blood-2004-10-3959","volume":"106","author":"S.K. Lee","year":"2005","unstructured":"Lee SK, Dykxhoorn DM, Kumar P, et al.: Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 2005, 106:818\u2013826.","journal-title":"Blood"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/JVI.80.2.571-577.2006","volume":"80","author":"R. Sabariegos","year":"2006","unstructured":"Sabariegos R, Gimenez-Barcons M, Tapia N, et al.: Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J Virol 2006, 80:571\u2013577.","journal-title":"J Virol"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-008-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-008-0006-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-008-0006-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-008-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:20:06Z","timestamp":1744165206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-008-0006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11904-008-0006-4","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"1 February 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}